SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-08-001669
Filing Date
2008-04-29
Accepted
2008-04-29 14:30:57
Documents
9
Period of Report
2008-06-18
Effectiveness Date
2008-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT w55489def14a.htm DEF 14A 540561
2 GRAPHIC w55489w5548907.gif GRAPHIC 3496
3 GRAPHIC w55489w5548900.gif GRAPHIC 1380
4 GRAPHIC w55489w5548902.gif GRAPHIC 5319
5 GRAPHIC w55489w5548901.gif GRAPHIC 3346
6 GRAPHIC w55489w5548903.gif GRAPHIC 386
7 GRAPHIC w55489w5548904.gif GRAPHIC 386
8 GRAPHIC w55489w5548905.gif GRAPHIC 732
9 GRAPHIC w55489w5548906.gif GRAPHIC 6206
  Complete submission text file 0000950133-08-001669.txt   572493
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 08784716
SIC: 2836 Biological Products, (No Diagnostic Substances)